Search Results for: good news

The valley of death: stem cells, biotechs, and money

What is the valley of death of science and biotech? For those of us conducting stem cell research, especially human stem cell research, I don’t have to tell you how expensive it is. Even just doing pre-clinical or basic science research costs a fortune. When you start talking about the kind of pre-clinical research specifically […]

The valley of death: stem cells, biotechs, and money Read More »

CIRM funds $25 million for Geron trial, $38 million for basic biology

Geron-300x2212

CIRM announced two sets of awards today that both should make major impact including its first clinical trial via Geron and $38 million for 27 basic biology studies. First Clinical Trial. Today CIRM awarded $25 million to support Geron’s FDA-approved clinical trial for spinal cord injury. This is CIRM’s first award to a for-profit company

CIRM funds $25 million for Geron trial, $38 million for basic biology Read More »

Victory for science and patients: what the appeals court ES cell ruling means (UPDATE)

judge-royce-lamberth

A Federal Appeals Court ruled 2-1 today to overturn Judge Lamberth’s injunction against federal funding of ES cell research. Great news! You can read the decision here (warning: big pdf). A key part of the ruling was the following: “the plaintiffs are unlikely to prevail because Dickey-Wicker is ambiguous and the NIH seems reasonably to

Victory for science and patients: what the appeals court ES cell ruling means (UPDATE) Read More »

Opponents of ES cell research launch stealth attack in Minnesota

Knoepfler lab stem cells

What’s going on with legislation on ES cell research in Minnesota? I blogged before about how Oklahoma legislators were heading toward passing legislation that would make it a crime to do ES cell research. Unfortunately, that legislation just passed. As if that were not bad enough, now potentially life saving research in Minnesota is starting

Opponents of ES cell research launch stealth attack in Minnesota Read More »

Stem cell biotech updates: Geron, ACT, Neuralstem, Pfizer

How is Geron doing along with other stem cell biotechs? What’s going on these days with biotech companies working on stem cell-based products? Geron and ACT Geron’s and Advanced Cell Technology (ACT)’s FDA-approved trials presumably continue. As expected, no news yet. It’s too soon. Two important questions regarding both these companies are (1) did they

Stem cell biotech updates: Geron, ACT, Neuralstem, Pfizer Read More »